What do a biotech business, sandal company, and software developer for tech headhunters have in common? No, that’s not the lead-in to a witty joke. The common thread between Longboard Pharmaceuticals, Birkenstock, and DHI Group is that they’re all commanding serious analyst attention, each receiving price target increases exceeding 40%. As I’m sure you’ll agree, the potential to rake in returns is no laughing matter!

These price upgrades come from well-regarded, top-rated analysts with stellar past performance metrics.

Longboard Pharmaceuticals (NASDAQ: LBPH)

Longboard Pharmaceuticals focuses on treatments for rare neurological conditions. Analyst Joshua Schimmer of Cantor Fitzgerald boosted its target price by 50% to $90. This upgrade suggests a 143% potential upside. Formed in 2020 by Arena Pharmaceuticals, this clinical-stage biopharmaceutical company is developing small-molecule medicines that target specific G protein-coupled receptors (GPCRs). GPCRs are the most promising class of targets in the human genome that can be affected by drugs, and the company’s research continues Arena’s 20+ years of drug development and optimization in this area.

Birkenstock Holding PLC (NYSE: BIRK)

Birkenstock is a legendary, centuries-old German shoe manufacturer. The company is known for its world-famous sandals and orthopedic shoe designs. UBS analyst Jay Sole gave the venerable firm a price target bump to $85, implying a 54% growth opportunity. Within the next few years, Birkenstock plans to double its production capacity, from 29.2 million to almost 60 million pairs of shoes. That’s a lot of shoes! The company maintains strict control over its supply chain and provides consistently high quality, even as it boosts production and expands into new markets. BIRK has attracted investors since going public just last year.

DHI Group (NYSE: DHX)

DHI Group operates specialized job platforms for technology professionals. Lake Street’s Eric Martinuzzi upped its price target to $3.50 from $2.50 by Eric Martinuzzi, indicating a possible 62% increase. Currently, the average price target for DHX is $5.25. The company’s tech recruitment platforms are ClearanceJobs and Dice. DHI provides AI-powered software, online tools, and talent acquisition services for comprehensive tech-focused career marketplaces. Catering to recruiters and job-seekers for more than 30 years, it specializes in highly skilled professionals across the tech industry, including candidates with government security clearances.

The substantial upside projections for these stocks suggest analysts see significant expansion opportunities in their respective markets. All three companies have consensus ratings as Strong Buys.

Neither Sean Kelland nor Stocks.News have positions in any of these companies.